Candriam S.C.A. Agilent Technologies, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 226,559 shares of A stock, worth $29.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

226,559

Previous 244,473 7.33%

Holding current value

$29.5 Million

Previous $31.7 Million 6.15%

% of portfolio

0.2%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$125.42 - $148.48 $2.25 Million - $2.66 Million	-17,914 Reduced 7.33%	226,559 $33.6 Million
Q2 2024 Aug 05, 2024	BUY	$129.63 - $154.64 $5.12 Million - $6.1 Million	39,468 Added 19.25%	244,473 $31.7 Million
Q1 2024 May 03, 2024	SELL	$128.12 - $149.31 $1.59 Million - $1.85 Million	-12,402 Reduced 5.7%	205,005 $29.8 Million
Q4 2023 Feb 14, 2024	SELL	$101.17 - $139.82 $3.65 Million - $5.04 Million	-36,047 Reduced 14.22%	217,407 $30.2 Million
Q3 2023 Nov 13, 2023	SELL	$109.73 - $128.47 $26.9 Million - $31.5 Million	-245,402 Reduced 49.19%	253,454 $28.3 Million
Q2 2023 Aug 08, 2023	SELL	$114.69 - $141.28 $2.29 Million - $2.82 Million	-19,970 Reduced 3.85%	498,856 $60 Million
Q1 2023 May 12, 2023	BUY	$131.13 - $159.06 $16.4 Million - $19.9 Million	125,170 Added 31.8%	518,826 $71.8 Million
Q4 2022 Feb 13, 2023	SELL	$125.64 - $157.68 $21.9 Million - $27.5 Million	-174,604 Reduced 30.73%	393,656 $58.9 Million
Q3 2022 Nov 10, 2022	BUY	$115.11 - $142.29 $7.83 Million - $9.68 Million	68,040 Added 13.6%	568,260 $60.1 Million
Q2 2022 Aug 03, 2022	BUY	$112.71 - $135.93 $3.42 Million - $4.13 Million	30,365 Added 6.46%	500,220 $59.4 Million
Q1 2022 May 13, 2022	SELL	$126.0 - $156.48 $21.5 Million - $26.7 Million	-170,705 Reduced 26.65%	469,855 $62.2 Million
Q4 2021 Feb 10, 2022	BUY	$147.95 - $164.3 $3.65 Million - $4.06 Million	24,704 Added 4.01%	640,560 $102 Million
Q3 2021 Nov 09, 2021	SELL	$147.58 - $179.28 $40,141 - $48,764	-272 Reduced 0.04%	615,856 $97 Million
Q2 2021 Jul 20, 2021	BUY	$127.69 - $148.81 $67.9 Million - $79.1 Million	531,392 Added 627.11%	616,128 $91.1 Million
Q1 2021 Apr 29, 2021	BUY	$114.99 - $130.12 $1,954 - $2,212	17 Added 0.02%	84,736 $9.65 Million
Q4 2020 Jan 22, 2021	BUY	$100.01 - $119.3 $1.91 Million - $2.27 Million	19,062 Added 29.03%	84,719 $10 Million
Q3 2020 Oct 19, 2020	BUY	$88.11 - $103.42 $2.04 Million - $2.4 Million	23,185 Added 54.59%	65,657 $6.63 Million
Q2 2020 Jul 23, 2020	SELL	$68.92 - $91.14 $2.49 Million - $3.29 Million	-36,149 Reduced 45.98%	42,472 $3.75 Million
Q1 2020 May 26, 2020	BUY	$63.37 - $90.13 $760 - $1,081	12 Added 0.02%	78,621 $6.56 Million
Q4 2019 Jan 21, 2020	BUY	$72.49 - $85.45 $329,901 - $388,882	4,551 Added 6.15%	78,609 $7,000
Q3 2019 Oct 21, 2019	SELL	$65.59 - $78.07 $891,171 - $1.06 Million	-13,587 Reduced 15.5%	74,058 $6,000
Q2 2019 Aug 01, 2019	SELL	$66.89 - $81.94 $662,946 - $812,107	-9,911 Reduced 10.16%	87,645 $6.52 Million
Q1 2019 May 02, 2019	SELL	$63.27 - $82.0 $22 Million - $28.6 Million	-348,302 Reduced 78.12%	97,556 $7.84 Million
Q4 2018 Feb 14, 2019	SELL	$61.13 - $74.67 $13.5 Million - $16.4 Million	-220,244 Reduced 33.06%	445,858 $30.1 Million
Q3 2018 Nov 07, 2018	BUY	$61.25 - $71.13 $6.68 Million - $7.75 Million	109,019 Added 19.57%	666,102 $47 Million
Q2 2018 Aug 14, 2018	BUY	$61.14 - $69.55 $8.5 Million - $9.67 Million	139,046 Added 33.26%	557,083 $34.5 Million
Q1 2018 May 09, 2018	BUY	$65.05 - $74.82 $12.6 Million - $14.5 Million	193,766 Added 86.4%	418,037 $28 Million
Q4 2017 Feb 07, 2018	SELL	$64.87 - $70.59 $7.33 Million - $7.98 Million	-113,030 Reduced 33.51%	224,271 $15 Million
Q3 2017 Nov 03, 2017	BUY	$58.57 - $66.17 $19.8 Million - $22.3 Million	337,301	337,301 $21.7 Million

Others Institutions Holding A

# of Institutions

1,148

Shares Held

253M

Call Options Held

974K

Put Options Held

939K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $38.6B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account